Almujtama Alraida Medical Swings to H1 Loss; Revenue Declines

02:31 AM EDT, 08/02/2026 (MT Newswires) -- Almujtama Alraida Medical (SASE:9592) said Sunday that it turned to a loss for the first half, while revenue dropped year over year. Net loss attributable to shareholders of the issuer for the six months ended June 30 was 4.9 million Saudi riyals, compared with the attributable profit of 4.3 million riyals a year ago. Loss per share moved to 0.52 riyal from EPS of 0.45 riyal. The Saudi Arabia-listed pharmacy operator's revenue was 184.3 million riyals, compared with 235 million riyals earlier.